Emerging Protein Bio therapeutics

Therapeutic proteins and monoclonal antibodies (MAb) have transformed biotechnology and the pharmaceutical industry. Together they form the largest part of the rapidly growing biologics drug market. Protein-based drugs include blood factors, thrombolytic agents, hormones, hematopoietic growth factors, interferons, interleukins, tumor necrosis factor, and therapeutic enzymes. 

  • Protein Particulate Detection Issues in Biotherapeutics Development
  • Analytical Development For Emerging Biotherapeutics
  • Automation And Emerging Analytical Methods
  • Bioanalytical Considerations Of Multi-Domain Biotherapeutics: Preclinical And Clinical Development

Related Conference of Emerging Protein Bio therapeutics

November 06-07, 2017

2nd International Conference on Autoimmunity

Frankfurt, Germany
November 08-09, 2017

3rd Antibodies and Bio Therapeutics Congress & B2B

Las Vegas, Nevada, USA
November 13-14, 2017

5th International Conference on HIV/AIDS, STDs and STIs

Las Vegas, Nevada, USA
Dec 14-15, 2017

World Immunology Congress

Dubai, UAE
May 28-29, 2018

World Congress on Allergy and Immunotherapy

Osaka, Japan

9th European Immunology Conference

June 14-16, 2018 Rome, Italy
July 12-13, 2018

5th International Conference on Parasitology

Paris, France

Emerging Protein Bio therapeutics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in